(Received for publication November 22, 1971) Carbenicillin is capable of inactivating gentamicin in vitro. This effect is time, temperature and medium dependent.
In vitro antibacterial tests demonstrate greater than additive activity in some instances and inactivation in others, particularly after prolonged incubation. Inactivation was not observed in vivo in mouse protection tests. Additive or more than additive combined activity in mouse protection tests occurred only infrequently. Intravenous administration of carbenicillin had no effect on gentamicin serum levels (given i.m.) in dogs although it did result in reduced recovery of gentamicin in the urine. This may have occurred after the urine had left the bladder. It is important that serum samples containing both gentamicin and carbenicillin be assayed shortly after drawing since inactivation can occur in these samples which then might be falsely interpreted as in vivo inactivation.
A number of studies have suggested that gentamicin and carbenicillin in vitro may act synergistically. Clinical studies have also appeared reporting the combined use of the two agents particularly in cases of Pseudomonas infections.
An article by McLaughlin and Reeves15 and comments2~5) and reply6) following it demonstrate that combining carbenicillin with gentamicin, at least in some in vitro situations, results in inactivation of gentamicin the rate of which is time, temperature and media depedent. such as might be anticipated in vivo was Serum of interest.
As shown in Table 3 , the degree of inactivation of gentamicin by carbenicillin was dependent on the relative checkerboard design was set up using 5 levels of gentamicin and 6 levels of carbenicillin.
Groups of 7 mice each were treated subcutane- of combined activity and are detailed in Table   6 . With both of these strains 500mg/kg of carbenicillin alone failed to protect any mice against death. These strains were also resistant to 50 mcg/ml of carbenicillin in vitro. However, gentamicin PD50 values decreased with both strains as carbenicillin levels were increased.
With one of two strains the decrease was mar-* No mice infected with either strain were protected by 500 mg/kg of carbenicilln alone.
ginal (strain 836) while with the other (strain 37) it was more dramatic. These were the only two instances of enhanced combined Table 7 . Gentamicin at 10mg/kg i.m. produced average peak serum levels of 15.5mcg/ml 1 hour after dosing. These declined to approximately 1.0mcg/ml 6hours after dosing. An average of 60% of the dose was excreted in the urine the first 24hours after dosing with an additional 3% excreted in the 25~48-hour period. Carbenicillin i.v. at a dose of 50mg/kg produced peak levels of 34.5mcg/ml which declined to 1.1 mcg/ml 6hours after dosing. Approximately 40 %of the carbenicillin dose was recovered in the urine. Carbenicillin (50mg/kg) given i.v. 1 hour before, at the same time, or 1 hour after the 10mg/kg gentamicin dose had no effect on gentamicin serum levels. Carbenicillin i.v. at 200mg/kg given at the same time as 10mg/kg of gentamicin likewise had no effect on gentamicin serum levels. Urine recovery of gentamicin however was significantly lower in all dogs treated with carbenicillin. This was most noticeable with the high carbenicillin level and when carbenicillin was given before the gentamicin. It is not known if this represents inactivation in the bladder or in the collection bottle prior to being collected for assay.
Serum samples from dogs showed a decrease in gentamicin levels when held at roomtemperature for more than a day prior to assay. It is important therefore that assays be done shortly after drawing the sample and that serum samples be frozen until assayed.
